Left Atrial Appendage (LAA) Closure Devices Market to Reach $8.2 Billion, Globally, by 2031 at a CAGR of 21%: Allied Market Research

ByLance T. Lee

Sep 16, 2022

Rising number of product approvals for atrial intervention and rise in atrial fibrillation, stroke cases, and hypertension-related diseases are driving the growth of the global closure devices market the left atrial appendage.

PORTLAND, Oregon., September 16, 2022 /PRNewswire/ — Allied Market Research has released a report titled, “Left Atrial Appendage (LAA) Closure Devices Market By Product (Endocardial LAA Devices, Epicardial LAA Devices), By End-Use (Hospitals, Ambulatory Surgery Centers, Others): Global Opportunities Analysis and Forecast industry, 2021-2031.” According to the report, the global left atrial appendage closure devices industry generated $1.3 billion in 2021, and should reach $8.2 billion by 2031, with a CAGR of 21.0% from 2022 to 2031.

Main determinants of growth

The increase in the number of product approvals for atrial intervention, the increase in atrial fibrillation, cases of stroke and hypertension-related diseases, as well as unhealthy lifestyle choices such as than smoking, are driving the growth of the global left atrial appendage closure devices market. Additionally, increasing awareness initiatives in untapped regions complements the growth of the market. However, the high cost of devices and the availability of substitutes in the market are limiting growth. On the other hand, the increase in the adoption of advanced technologies and the improvement in the efficiency of implants and the safety of procedures present opportunities in the market.

Download Sample Report – https://www.alliedmarketresearch.com/request-sample/3699

Covid-19 scenario

  • The Covid-19 pandemic has had a significant impact on the Left Atrial Appendage Closure Devices market. LAA closure device development and manufacturing activities have been halted due to containment restrictions and the unavailability of sufficient raw materials.
  • Additionally, hospitals and health authorities have issued cancellations or postponements of elective procedures such as interventional structural heart surgeries (SH) to reduce patient exposure to Covid-19 infection and preserve capacity. intensive care units to care for patients infected with Covid.
  • The limited availability of critical care and anesthesiology beds has led to considerable barriers in performing elective structural cardiac procedures, including LAA closure procedures, and reduced use of cardiac closure devices. the AGA. This had a negative impact on revenue.
  • However, the market is expected to recover post-pandemic as SH interventional surgeries are back on track with vaccination programs and other preventative measures in place.

The LAA Endocardial Devices Segment to Maintain Its Leading Position During the Forecast Period

Based on product, the LAA endocardial device segment contributed the highest market share in 2021, accounting for approximately 90% of the global left atrial appendage closure device market, and is expected to maintain its leading position during the forecast period. Additionally, this segment is estimated to have the highest CAGR of 21.2% from 2022 to 2031. This is due to lower patient complications, shorter hospital stays, and safer and more efficient management. effective stroke and bleeding than other products. The report also analyzes the epicardial LAA devices segment.

The Hospitals segment will continue its highest contribution throughout the forecast period

Based on end-use, the hospital segment accounted for the largest market share in 2021, holding approximately three-quarters of the global left atrial appendage closure devices market, and is expected to maintain its highest contribution throughout the forecast period. Additionally, this segment is expected to register the fastest CAGR of 21.4% from 2022 to 2031. This is due to the preference for left atrial appendage (LAA) procedures and increasing acceptance by AGA closure devices hospitals through the availability of advanced medical technologies and qualified personnel. professionals. The research also analyzes the segments including day surgery centers and others.

For Purchase Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/3699

North America maintain its revenue dominance over the forecast period

Based on the region, North America held the largest market share in 2021, accounting for nearly half of the global left atrial appendage closure devices market, and is expected to maintain its revenue dominance over the forecast period. This is due to the widespread acceptance of advanced left atrial appendage closure devices, the increasing incidence of atrial fibrillation, and a well-developed healthcare infrastructure. However, Asia Pacific is expected to grow at the highest CAGR of 22.2% from 2022 to 2031, driven by strong preference and acceptance of advanced technologies in closure devices in medical institutions in the region.

Main market players

  • SentreHEART, Inc.
  • Boston Scientific Society
  • Atricure, Inc.
  • Abbott Laboratories
  • oclutech
  • Lifetech Scientific Society
  • Cardia, Inc.
  • Aegis Medical Group
  • Biosense Webster, Inc.
  • Johnson & Johnson Services, Inc.

Official Press Release – https://www.alliedmarketresearch.com/press-release/left-atrial-appendage-laa-closure-device-market.html

Similar research reports for information, communication and technology:

Dialysis Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Medical Electrodes Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Tattoo Removal Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Neurovascular Devices Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Assistive Devices for Elderly and Disabled Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

AVENUE – A subscription-based library (Premium on-demand, subscription-based pricing model):

AMR introduces its premium subscription-based Avenue online library, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

Access the report library anytime from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business advisory division of Allied Analytics LLP based in Portland, OR. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services across 11 verticals, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. CEO of Allied Market Research Pawan Kumar is essential to inspire and encourage everyone associated with the business to maintain high quality data and help customers in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
hong kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

SOURCE Allied Market Research


Source link